{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:38:46Z","timestamp":1788975526216,"version":"build-2803163510"},"reference-count":47,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019174","name":"Australian Companion Animal Health Foundation","doi-asserted-by":"publisher","award":["2017\/015"],"award-info":[{"award-number":["2017\/015"]}],"id":[{"id":"10.13039\/501100019174","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Feline Health Research Fund","award":["2017"],"award-info":[{"award-number":["2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Although the antibody response induced by primary vaccination with Fel-O-Vax\u00ae FIV (three doses, 2\u20134 weeks apart) is well described, the antibody response induced by annual vaccination with Fel-O-Vax\u00ae FIV (single dose every 12 months after primary vaccination) and how it compares to the primary antibody response has not been studied. Residual blood samples from a primary FIV vaccination study (n = 11), and blood samples from cats given an annual FIV vaccination (n = 10), were utilized. Samples from all 21 cats were tested with a commercially available PCR assay (FIV RealPCRTM), an anti-p24 microsphere immunoassay (MIA), an anti-FIV transmembrane (TM; gp40) peptide ELISA, and a range of commercially available point-of-care (PoC) FIV antibody kits. PCR testing confirmed all 21 cats to be FIV-uninfected for the duration of this study. Results from MIA and ELISA testing showed that both vaccination regimes induced significant antibody responses against p24 and gp40, and both anti-p24 and anti-gp40 antibodies were variably present 12 months after FIV vaccination. The magnitude of the antibody response against both p24 and gp40 was significantly higher in the primary FIV vaccination group than in the annual FIV vaccination group. The differences in prime versus recall post-vaccinal antibody levels correlated with FIV PoC kit performance. Two FIV PoC kits that detect antibodies against gp40, namely Witness\u00ae and Anigen Rapid\u00ae, showed 100% specificity in cats recently administered an annual FIV vaccination, demonstrating that they can be used to accurately distinguish vaccination and infection in annually vaccinated cats. A third FIV PoC kit, SNAP\u00ae Combo, had 0% specificity in annually FIV-vaccinated cats, and should not be used in any cat with a possible history of FIV vaccination. This study outlines the antibody response to inactivated Fel-O-Vax\u00ae FIV whole-virus vaccine, and demonstrates how best to diagnose FIV infection in jurisdictions where FIV vaccination is practiced.<\/jats:p>","DOI":"10.3390\/v13030470","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T02:51:48Z","timestamp":1615776708000},"page":"470","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax\u00ae FIV)"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-1960","authenticated-orcid":false,"given":"Mark","family":"Westman","sequence":"first","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Yang","sequence":"additional","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Green","sequence":"additional","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0003-6930","authenticated-orcid":false,"given":"Jacqueline","family":"Norris","sequence":"additional","affiliation":[{"name":"Sydney School of Veterinary Science, The University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-194X","authenticated-orcid":false,"given":"Richard","family":"Malik","sequence":"additional","affiliation":[{"name":"Centre for Veterinary Education, The University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-6698","authenticated-orcid":false,"given":"Yasmin A.","family":"Parr","sequence":"additional","affiliation":[{"name":"MRC, University of Glasgow Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"McDonald","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Services, The University of Glasgow, Glasgow G61 1QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4313-5023","authenticated-orcid":false,"given":"Margaret J.","family":"Hosie","sequence":"additional","affiliation":[{"name":"MRC, University of Glasgow Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-1622","authenticated-orcid":false,"given":"Sue","family":"VandeWoude","sequence":"additional","affiliation":[{"name":"1619 Campus Delivery, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-5665","authenticated-orcid":false,"given":"Craig","family":"Miller","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Oklahoma State University, 250 McElroy Hall, Stillwater, OK 74078, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0b013e328013d88a","article-title":"Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine","volume":"21","author":"Yamamoto","year":"2007","journal-title":"AIDS"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/CMR.00009-06","article-title":"Going wild: Lessons from naturally occurring T-lymphotropic lentiviruses","volume":"19","author":"VandeWoude","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.3643650","article-title":"Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome","volume":"235","author":"Pedersen","year":"1987","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vetimm.2014.02.014","article-title":"FIV in cats\u2014A useful model of HIV in people?","volume":"159","author":"Bienzle","year":"2014","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.cvsm.2011.07.003","article-title":"Feline immunodeficiency virus: Disease association versus causation in domestic and nondomestic felids","volume":"41","author":"White","year":"2011","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sahay, B., and Yamamoto, J.K. (2018). Lessons learned in developing a commercial FIV vaccine: The immunity required for an effective HIV-1 vaccine. Viruses, 10.","DOI":"10.3390\/v10050277"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2006.03.013","article-title":"Lessons from the cat: Development of vaccines against lentiviruses","volume":"112","author":"Dunham","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vetimm.2008.01.030","article-title":"Advances in FIV vaccine technology","volume":"123","author":"Uhl","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1939-1676.2008.0078.x","article-title":"Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats","volume":"22","author":"Levy","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vetmic.2014.01.014","article-title":"Diagnostic utility of CD4%:CD8(low)% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats","volume":"170","author":"Litster","year":"2014","journal-title":"Vet. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cimid.2015.07.004","article-title":"Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits","volume":"42","author":"Westman","year":"2015","journal-title":"Comp. Immun. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Arora, D.R., Maheshwari, M., and Arora, B. (2013). Rapid point-of-care testing for detection of HIV and clinical monitoring. ISRN AIDS, 2013.","DOI":"10.1155\/2013\/287269"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1258\/095646206777323418","article-title":"A review of HIV point-of-care tests","volume":"17","author":"Dewsnap","year":"2006","journal-title":"Int. J. STD AIDS"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/157016210790416361","article-title":"Feline immunodeficiency virus model for designing HIV\/AIDS vaccines","volume":"8","author":"Yamamoto","year":"2010","journal-title":"Curr. HIV Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-2427(02)00227-1","article-title":"FIV vaccine development and its importance to veterinary and human medicine: FIV vaccine 2002 update and review","volume":"90","author":"Uhl","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cvsm.2006.11.011","article-title":"New challenges for the diagnosis of feline immunodeficiency virus infection","volume":"37","author":"Crawford","year":"2007","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jfms.2008.03.002","article-title":"2008 American Association of Feline Practitioners\u2019 feline retrovirus management guidelines","volume":"10","author":"Levy","year":"2008","journal-title":"J. Feline Med. Surg."},{"key":"ref_18","unstructured":"(2016, February 11). Available online: http:\/\/www.wsava.org\/sites\/default\/files\/VaccinationGuidelines2010.pdf."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cimid.2016.03.006","article-title":"Diagnosing feline immunodeficiency virus (FIV) infection in FIV-vaccinated and FIV-unvaccinated cats using saliva","volume":"46","author":"Westman","year":"2016","journal-title":"Comp. Immun. Microbiol. Infect. Dis."},{"key":"ref_20","first-page":"1475","article-title":"Does a DIVA test exist for differentiating FIV infection from FIV vaccination? (2016 ACVIM Forum Research Abstract Program)","volume":"30","author":"Crawford","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/1098612X16673292","article-title":"Duration of antibody response following vaccination against feline immunodeficiency virus","volume":"19","author":"Westman","year":"2017","journal-title":"J. Feline Med. Surg."},{"key":"ref_22","unstructured":"(2016, April 25). Available online: http:\/\/www.wsava.org\/sites\/default\/files\/WSAVA%20Vaccination%20Guidelines%202015%20Full%20Version.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jfms.2007.04.003","article-title":"Quality of different in-clinic test systems for feline immunodeficiency virus and feline leukaemia virus infection","volume":"9","author":"Hartmann","year":"2007","journal-title":"J. Feline Med. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jvim.14648","article-title":"Performance of 4 point-of-care screening tests for feline leukemia virus and feline immunodeficiency virus","volume":"31","author":"Levy","year":"2017","journal-title":"J. Vet. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2013.08.001","article-title":"Domestic cat microsphere immunoassays: Detection of antibodies during feline immunodeficiency virus infection","volume":"396","author":"Wood","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Miller, C., Emanuelli, M., Fink, E., Musselman, E., Mackie, R., Troyer, R., Elder, J., and VandeWoude, S. (2018). FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge. NPJ Vaccines, 3.","DOI":"10.1038\/s41541-018-0051-y"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/CVI.00289-10","article-title":"Development and validation of a multiplex microsphere-based assay for detection of domestic cat (Felis catus) cytokines","volume":"18","author":"Wood","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_28","unstructured":"Harris, M. (2018). Studies towards the Development of an FIV DIVA Vaccine. [Ph.D. Thesis, University of Glasgow]."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/jcm.25.4.600-604.1987","article-title":"Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays","volume":"25","author":"Classen","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0923-2516(06)80031-2","article-title":"Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins","volume":"144","author":"Avrameas","year":"1993","journal-title":"Res. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cimid.2007.07.007","article-title":"Vaccination against the feline immunodeficiency virus: The road not taken","volume":"31","author":"Lecollinet","year":"2008","journal-title":"Comp. Immun. Microbiol. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.vetmic.2006.10.038","article-title":"Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats","volume":"120","author":"Kusuhara","year":"2007","journal-title":"Vet. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1079\/AHR200487","article-title":"Efficacy and safety of a feline immunodeficiency virus vaccine","volume":"5","author":"Huang","year":"2004","journal-title":"An. Health Res. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jfms.2009.12.016","article-title":"Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge","volume":"12","author":"Huang","year":"2010","journal-title":"J. Feline Med. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vetmic.2005.02.014","article-title":"Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats","volume":"108","author":"Kusuhara","year":"2005","journal-title":"Vet. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/v3101870","article-title":"Feline immunodeficiency virus (FIV) neutralization: A review","volume":"3","author":"Hosie","year":"2011","journal-title":"Viruses"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.vaccine.2013.05.024","article-title":"Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.vaccine.2004.05.032","article-title":"Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine","volume":"23","author":"Omori","year":"2004","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1607S","DOI":"10.1093\/jn\/132.6.1607S","article-title":"Assessing age-related changes in peripheral blood leukocyte phenotypes in domestic shorthaired cats using flow cytometry","volume":"132","author":"Heaton","year":"2002","journal-title":"J. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vetimm.2004.03.002","article-title":"Age-related differences in parameters of feline immune status","volume":"100","author":"Campbell","year":"2004","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/1096-9071(200104)63:4<293::AID-JMV1004>3.0.CO;2-C","article-title":"Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects","volume":"63","author":"Cools","year":"2001","journal-title":"J. Med. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JCM.02584-13","article-title":"Detection of antibodies to the feline leukemia virus (FeLV) transmembrane protein p15E: An alternative approach for serological FeLV detection based on antibodies to p15E","volume":"52","author":"Boenzli","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1098612X11432240","article-title":"Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines","volume":"14","author":"Lappin","year":"2009","journal-title":"J. Feline Med. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2460\/javma.1991.199.10.1413","article-title":"Feline leukemia virus vaccine development","volume":"199","author":"Sebring","year":"1991","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1016\/j.vaccine.2005.01.080","article-title":"Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults","volume":"23","author":"McElhaney","year":"2005","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/1098612X17747740","article-title":"Antibody response to feline panleukopenia virus vaccination in healthy adult cats","volume":"20","author":"Bergmann","year":"2018","journal-title":"J. Feline Med. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1098612X11432239","article-title":"Effects of maternally-derived antibodies on serologic responses to vaccination in kittens","volume":"14","author":"DiGangi","year":"2012","journal-title":"J. Feline Med. Surg."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/3\/470\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:34:53Z","timestamp":1760160893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/3\/470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["v13030470"],"URL":"https:\/\/doi.org\/10.3390\/v13030470","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]}}}